“Long-Term Efficacy of Ritlecitinib up to Month 24 From the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata” (2024) SKIN The Journal of Cutaneous Medicine, 8(2), p. s394. doi:10.25251/skin.8.supp.394.